Anus Neoplasms clinical trials
The registry lists 265 studies for Anus Neoplasms across more than 10 countries. 70 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-25.
Status
- Completed
- 112
- Recruiting
- 57
- Active, not recruiting
- 26
- Terminated
- 26
- Status unknown
- 23
- Not yet recruiting
- 10
Phase
- Phase 2
- 75
- Phase 1
- 51
- Phase 3
- 23
Where
- United States
- 144
- France
- 29
- China
- 14
- Canada
- 14
- Australia
- 13
- United Kingdom
- 12
Who runs them
National Cancer Institute (NCI) (21) · AIDS Malignancy Consortium (11) · M.D. Anderson Cancer Center (8) · Stanford University (6) · University Health Network, Toronto (5) · UNICANCER (4) · Centre Hospitalier Universitaire de Besancon (4) · Memorial Sloan Kettering Cancer Center (4)
Studies
Recruiting first, then most recently updated. Showing 50 of 265 — search for more.
- DESTINY-PANTUMOUR04RecruitingNCT071240001 country
- Shortening Radiation Course Duration Using Simultaneous Integrated Boost With Lower Intensity Elective Nodal Dosing and Concurrent Chemotherapy for High-Risk Anal Squamous Cell CarcinomaEnrolling by invitationNCT07775209Phase 21 country
- EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.RecruitingNCT06263088Not applicable1 country
- A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell CarcinomasRecruitingNCT07217171Phase 11 country
- Mind-Body Sexual Well-Being Program for Female GI Cancer SurvivorsNot yet recruitingNCT07795801Not applicable1 country
- A Study of IDP-001 in Advanced or Metastatic Solid TumorsRecruitingNCT07602842Phase 1/21 country
- Ovarian-Sparing Adaptive Radiotherapy in Young Adult WomenRecruitingNCT069043651 country
- Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)RecruitingNCT077821641 country
- Swabs in Screening for HPV (SWISH)Not yet recruitingNCT07790601Not applicable1 country
- Radiation Therapy for the Treatment of Metastatic Gastrointestinal CancersRecruitingNCT04221893Not applicable1 country
- ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal CancerRecruitingNCT07425054Phase 21 country
- SMP-3124LP in Adults With Advanced Solid TumorsRecruitingNCT06526819Phase 1/22 countries
- Distance-Based Exercise to Preserve Function and Prevent DisabilityRecruitingNCT07059884Not applicable1 country
- A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsRecruitingNCT06270706Phase 11 country
- Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal CancerRecruitingNCT06493019Phase 21 country
- Disease Evolution and Risk Factors of AIDS-related Prevalent CancersNot yet recruitingNCT07696169
- Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell CarcinomaRecruitingNCT07692152Phase 31 country
- Phase 2 Study of Pembrolizumab and Lenvatinib in Anal Squamous Cell CancerNot yet recruitingNCT07680088Phase 2
- Integrated Cancer Repository for Cancer ResearchRecruitingNCT020126991 country
- COQ10 and Vitamin E for Off-Target Radiation ToxicityNot yet recruitingNCT07668284Phase 1/21 country
- E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated CancersRecruitingNCT05686226Phase 21 country
- E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated CancersRecruitingNCT05639972Phase 1/21 country
- MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized ApproachRecruitingNCT06050707Phase 23 countries
- Improving Clinic Delivery of HIV-related Anal Health ServicesNot yet recruitingNCT07464236Not applicable1 country
- Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related CancersRecruitingNCT056635021 country
- Blood Biomarkers Based Screening for HPV-driven OPCNot yet recruitingNCT06528353Not applicable
- Self-sampling to Optimize Anal Lesion OutcomesRecruitingNCT07192055Not applicable1 country
- Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure ProphylaxisRecruitingNCT07029152Not applicable1 country
- Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：ChaseRecruitingNCT07555678Phase 21 country
- Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal CancerRecruitingNCT07407647Phase 21 country
- Agnostic Therapy in Rare Solid TumorsRecruitingNCT06638931Phase 21 country
- Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal StudyNot yet recruitingNCT07523152Not applicable
- Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic RadiotherapyRecruitingNCT04094454Not applicable1 country
- Detecting HPV DNA in Anal and Cervical CancersRecruitingNCT048575281 country
- Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesRecruitingNCT04907643Not applicable1 country
- HPV Genotype Attribution and Disease Burden of Anal Cancer in ChinaRecruitingNCT066704951 country
- Adaptive Radiation in Anal CancerRecruitingNCT05838391Not applicable1 country
- Ganglion Impar Neurolysis for the Improvement of Radiation-Induced Pain During Localized Anal or Perianal Skin Cancer TreatmentRecruitingNCT07112690Not applicable1 country
- An Early Access Program Guideline to Provide Access to Retifanlimab (INCMGA00012) Together With Carboplatin and Paclitaxel for Squamous Carcinoma of the Anal Canal (SCAC)AvailableNCT06910137
- Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal CancerRecruitingNCT072962371 country
- Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY TrialRecruitingNCT06522256Not applicable1 country
- A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid TumorsRecruitingNCT05941507Phase 1/22 countries
- Deciphering Mechanisms Underlying Cancer ImmunogenicityRecruitingNCT03958240Not applicable1 country
- Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCARecruitingNCT06207981Phase 32 countries
- Patient Reported Outcomes (PROs) in Anal Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT).RecruitingNCT063645791 country
- Screening Women With Prior HPV for Anal NeoplasiaRecruitingNCT05217940Not applicable1 country
- Stigma and Psychological profilE in REctal-anal caNcer pAtientsRecruitingNCT063668411 country
- Identification of the Pathogenetic Mechanisms Underlying Squamous Cell CarcinomasRecruitingNCT062364641 country
- Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.RecruitingNCT06574087Not applicable1 country
- Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.RecruitingNCT03061435Not applicable1 country